Source: National Institutes of Health Press Release. September 3, 2019. NIH launches novel nationwide search for neuroprotective stroke therapies.

PsychoGenics Inc. (PsychoGenics) today announced it has been awarded a contract by the National Institutes of Health (NIH) to test and identify novel ...

An ultra-sensitive blood test that reflects brain damage after acute ischemic stroke - and also predicts functional outcome. This is a discovery that is expected to be of great significance in the ...

The study was conducted by the National Institute of Neurological Disorders and Stroke, a part of the National Institutes of Health (NIH). Findings appear in the Jan. 27, 2007, edition of the Lancet.